Cosmos Health Inc. (COSM)
COSM trades on Nasdaq in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3829
+9.53% on the day
Market cap
$38.5M
Nano cap
Revenue · 2025
$65.3M
+19.9% on 2024
Net income · 2025
-$19.1M
-29.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | COSM on Nasdaq |
| Sector | Health Care |
| Industry | Other Pharmaceuticals |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001474167 |
| SEC industry code | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $65.3M |
| Net income | -$19.1M |
| Operating income | -$16.7M |
| Net margin | -29.3% |
| Operating margin | -25.6% |
| Revenue growth | +19.9% |
| Cash | $716K |
| Total assets | $65.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-12-19 |
| Latest annual report FORM 10-K | 10-K | 2026-04-15 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-18 |
| Latest current report FORM 8-K | 8-K | 2026-10-09 |
| Latest proxy | DEFA14A | 2026-06-05 |
Source: SEC EDGAR submissions feed, 632 recent filings. All filings on EDGAR.
Peers in Other Pharmaceuticals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ESYN | EnerSyn Global Inc. | $2.03 | +3.57% | $60.3M |
| ZSTK | ZeroStack Corp. | $4.37 | 0.00% | $95.4M |
| MEDS | DataMeds AI Inc. | $3.03 | -1.30% | $13.7M |
| NUS | Nu Skin Enterprises Inc. | $5.01 | +2.88% | $243.9M |
| HKPD | Cellyan Biotechnology Co. Ltd | $0.1049 | -1.59% | $5.1M |
| HLF | Herbalife Ltd. Common Shares | $14.21 | +4.41% | $1.5B |
| CAH | Cardinal Health Inc. | $239.72 | +0.69% | $55.5B |
| COR | Cencora Inc. | $330.11 | +1.55% | $63.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier